Transition from antigenemia to quantitative nucleic acid amplification testing in cytomegalovirus-seropositive kidney transplant recipients receiving preemptive therapy for cytomegalovirus infection

Due to the high costs, the strategy to reduce the impact of cytomegalovirus (CMV) after kidney transplant (KT) involves preemptive treatment in low and middle-income countries. Thus, this retrospective cohort study compared the performance of antigenemia transitioned to quantitative nucleic acid amp...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakamura, Mônica Rika, Requião-Moura, Lúcio R., Gallo, Roberto Mayer, Botelho, Camila, Taddeo, Júlia, Viana, Laila Almeida, Felipe, Cláudia Rosso, Medina-Pestana, José, Tedesco-Silva, Hélio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9329426/
https://www.ncbi.nlm.nih.gov/pubmed/35896770
http://dx.doi.org/10.1038/s41598-022-16847-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9329426/
https://www.ncbi.nlm.nih.gov/pubmed/35896770
http://dx.doi.org/10.1038/s41598-022-16847-3

Ejemplares similares